Bruno Medeiros

Bruno Medeiros is a medical professional with extensive experience in hematology and oncology, particularly focused on leukemia research and treatment. Here are some key details about his background and current role:

Professional Experience

Bruno Medeiros currently serves as the Executive Medical Director and Global Head of Leukemia Strategy at AstraZeneca.3 Prior to this, he held several positions including:

• Group Medical Director at AbbVie (April 2022 - Present)1
• Senior Medical Director at AbbVie (April 2021 - April 2022)1
• Medical Director at Genentech (May 2018 - April 2021)1

Academic Career

Medeiros has had a long association with Stanford University:

• Adjunct Professor (May 2018 - Present)1
• Associate Professor (August 2014 - May 2018)1
• Assistant Professor (August 2006 - August 2014)1

Education and Training

• Medical Degree: Universidade Federal do Parana, Brazil (1998)2
• Fellowship: University of Colorado Denver Hematology and Oncology Fellowship2
• Fellowship in Acute Leukemia: Princess Margaret Hospital - University of Toronto2

Clinical and Research Focus

Dr. Medeiros specializes in:

• Management of advanced hematologic malignancies, including AML, ALL, MDS, and CML2
• Development of novel therapeutic regimens for acute leukemia patients2
• Translational research in acute leukemia2

He has authored over 120 peer-reviewed manuscripts and has been actively involved in multiple clinical trials and research initiatives.2

Professional Activities

• Served as track leader for ASCO meeting Leukemia, Myelodysplasia and Transplantation scientific review subcommittee2
• Associate Editor of the Leukemia Panel for Cancer.Net2
• Member of the editorial board for Leukemia Research2
• Reviewer for specialized journals such as Blood, Leukemia, Haematologica, and Cancer2

Bruno Medeiros has made significant contributions to the field of leukemia research and treatment throughout his career, combining clinical practice, academic research, and pharmaceutical industry roles.